EMV Capital plc is a deep tech and life sciences venture capital investment group with an international portfolio of high-growth companies.
With a strategic focus on generating superior returns for investors from the fast-growing sectors and technologies that will define our future, the group invests in, manages, and strengthens early stage IP-rich companies.
Small Caps
EMV Capital: AMR Bio targets FDA meeting to clear path for XF-73 Phase 3 trial
Small Caps
EMV Capital: ProAxsis eyes COPD market breakthrough with Imperial College London study
